Evidence map›Paper›PMID 39313716›Full record

ArticleJournal of imaging informatics in medicine2025

A Robust Deep Learning Method with Uncertainty Estimation for the Pathological Classification of Renal Cell Carcinoma Based on CT Images.

Ni Yao, Hang Hu, Kaicong Chen, Huan Huang, Chen Zhao, Yuan Guo, Boya Li, Jiaofen Nan, Yanting Li, Chuang Han and 3 more

Abstract read
In one paragraph

Article in Journal of imaging informatics in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ni YaoSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Hang HuSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Kaicong ChenDepartment of Medical Imaging, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.
Huan HuangSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Chen ZhaoDepartment of Applied Computing, Michigan Technological University, Houghton, MI, USA.
Yuan GuoDepartment of Radiology, The First People's Hospital of Guangzhou, Guangzhou, 510180, Guangdong, China.
Boya LiDepartment of Medical Imaging, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China.
Jiaofen NanSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Yanting LiSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Chuang HanSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Fubao ZhuSchool of Computer Science and Technology, Zhengzhou University of Light Industry, Zhengzhou, 450002, Henan, China.
Weihua ZhouDepartment of Applied Computing, Michigan Technological University, Houghton, MI, USA. whzhou@mtu.edu.
Li TianDepartment of Medical Imaging, State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, 510060, Guangdong, China. tianli@sysucc.org.cn.ORCID http://orcid.org/0000-0001-6891-8414

Funding

Henan Science and Technology Development Plan 222102210219Henan Science and Technology Development Plan 232102210010Henan Science and Technology Development Plan 232102210062Henan Science and Technology Development Plan 232102211003National Natural Science Foundation of China 62106233National Natural Science Foundation of China 62303427National Natural Science Foundation of China 62476255National Natural Science Foundation of China 82370513
6 · The paper itself

Abstract

This study developed and validated a deep learning-based diagnostic model with uncertainty estimation to aid radiologists in the preoperative differentiation of pathological subtypes of renal cell carcinoma (RCC) based on computed tomography (CT) images. Data from 668 consecutive patients with pathologically confirmed RCC were retrospectively collected from Center 1, and the model was trained using fivefold cross-validation to classify RCC subtypes into clear cell RCC (ccRCC), papillary RCC (pRCC), and chromophobe RCC (chRCC). An external validation with 78 patients from Center 2 was conducted to evaluate the performance of the model. In the fivefold cross-validation, the area under the receiver operating characteristic curve (AUC) for the classification of ccRCC, pRCC, and chRCC was 0.868 (95% CI, 0.826-0.923), 0.846 (95% CI, 0.812-0.886), and 0.839 (95% CI, 0.802-0.88), respectively. In the external validation set, the AUCs were 0.856 (95% CI, 0.838-0.882), 0.787 (95% CI, 0.757-0.818), and 0.793 (95% CI, 0.758-0.831) for ccRCC, pRCC, and chRCC, respectively. The model demonstrated robust performance in predicting the pathological subtypes of RCC, while the incorporated uncertainty emphasized the importance of understanding model confidence. The proposed approach, integrated with uncertainty estimation, offers clinicians a dual advantage: accurate RCC subtype predictions complemented by diagnostic confidence metrics, thereby promoting informed decision-making for patients with RCC.

Indexed as

Carcinoma, Renal CellDeep LearningKidney NeoplasmsTomography, X-Ray ComputedAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedRetrospective StudiesUncertaintyComputed tomographyDeep learningPathological classificationRenal cell carcinoma

Identifiers

PMID39313716
PMCPMC12092889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.